Defining Difficult to Treat Rheumatoid Arthritis
Oct 01, 2020
Latest ACR News
-
‘Difficult-to-treat RA’ is an oft-used term that carries various clinical qualities and therapeutic disappointments. A EULAR Task Force was established to develop recommendations for the management of difficult-to-treat rheumatoid arthritis and as a first step, have put forth their definition of this rheumatoid arthritis (RA) subset.Read Article
Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.
Making Better Posters: Dr. David Liew
Dr. David Liew describes how some presenters are working to make their posters better design-wise to improve their presentation at the 2019 ACR/ARP annual meeting in Atlanta.
Dr Irwin Lim _connectedcare
10 months 2 weeks ago
Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessation Anecdotally, there are people who do well on pragmatic, long term low dose eg 5mg or less/d #ACR19 @rheumnow Abst1760 https://t.co/FtE9vHb655
Dr. John Cush RheumNow
10 months 2 weeks ago
#ACR19 Rheumatology RoundUp - Kavanaughs Picks:
2505 PsA prevention
1366 Self Joint exams
1120 Rheum burnout
1310 OA Hx
565 Enteropathic arthritis Recs
1823 MRE dx of SI
2773 Machine learning
2772 Antiinflammatory diet in RA
1359 Synovial Bx
Dr. John Cush RheumNow
10 months 2 weeks ago
#ACR19 Rheumatology RoundUp - Cushs Abstract Picks:
1223 ALLN-346 Urate Degrading Enzyme
L06 Emapalumab in MAS
1890 2357 MTX Safety
1240 anaGO
2292 2279 Biologic WD in Preg
633 631 AS Delays in Dx & referral
196 VTE & ASCVD
2566 Polypharmacy in SLE
Jonathan Hausmann MD hausmannMD
10 months 2 weeks ago
CAPS is caused by mutations in NLRP3, a component of the inflammasome.
It is thought that NLRP3 mutations lead to the uncontrolled production of the inflammatory cytokine IL-1b.
Jonathan Hausmann MD hausmannMD
10 months 2 weeks ago
Patients with more severe #CAPS phenotypes may develop hearing loss, amyloidosis, aseptic meningitis, intellectual impairment, or #arthritis.
Jonathan Hausmann MD hausmannMD
10 months 2 weeks ago
Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #ACR19 @RheumNow
Jonathan Hausmann MD hausmannMD
10 months 2 weeks ago
"I usually do not" give methotrexate to men with RA who are trying to conceive. Dr. Bathon.
"But methotrexate is in serum for brief periods, unlikely to affect semen, unlikely to affect pregnancy." Dr. Bykerk #ACR19 @RheumNow
Jonathan Hausmann MD hausmannMD
10 months 2 weeks ago
Awesome to meet new people from across the globe, catch up with old friends, and discuss why #ACR20 should have abundant free food! https://t.co/lEdYZM9BHB
Jonathan Hausmann MD hausmannMD
10 months 2 weeks ago
However, 15-30% of patients with acute pericarditis develop recurrent pericarditis
Jonathan Hausmann MD hausmannMD
10 months 2 weeks ago
Recurrent pericarditis (RP) is the recurrence of pericarditis after a more than 4-6 week symptom-free period.
RP is typically treated with steroids, colchicine, NSAIDs.
Nevertheless, RP is associated with a high burden of disease and there is an unmet need for better treatment.
Dr. Antoni Chan synovialjoints
10 months 2 weeks ago
The highlight of the last day of #ACR19 is the Rheumatology Roundup Highlights #ACRBest by Drs. John Cush @RheumNow and Arthur Kavanaugh @ACRheum always worth attending with great take home messages #rheum https://t.co/eMdvc2byKG
Expanded coverage of ACR19 Annual Meeting is sponsored by:
All content chosen and published by RheumNow and faculty
Featured Video
Key Conference Topics
Additional Topics
Recent Podcasts
RheumNow Podcast – Cardiovascular Risk in Psoriatic Disease (9.25.20)Sep 25, 2020-
Lupus DelightsSep 18, 2020
-
RheumNow Podcast - ACR Reproductive Health Slides (9-11-20)Sep 11, 2020